Frequent promoter methylation of CDH1, DAPK, RARB, and HIC1 genes in carcinoma of cervix uteri: its relationship to clinical outcome - Test2 - elhamkhani - TriplyDB

Frequent promoter methylation of CDH1, DAPK, RARB, and HIC1 genes in carcinoma of cervix uteri: its relationship to clinical outcome

Frequent promoter methylation of CDH1, DAPK, RARB, and HIC1 genes in carcinoma of cervix uteri: its relationship to clinical outcome

http://www.wikidata.org/entity/Q24800480

about

Integrative genomics analysis of chromosome 5p gain in cervical cancer reveals target over-expressed genes, including Drosha The aryl hydrocarbon receptor repressor is a putative tumor suppressor gene in multiple human cancers First anniversary of Molecular Cancer: achievements and future goals Chromosomal amplifications, 3q gain and deletions of 2q33-q37 are the frequent genetic changes in cervical carcinoma A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes Epigenetics of cervical cancer. An overview and therapeutic perspectives DAPK1 Promoter Methylation and Cervical Cancer Risk: A Systematic Review and a Meta-Analysis Down-regulation of the transcriptional mediator subunit Med1 contributes to the loss of expression of metastasis-associated dapk1 in human cancers and cancer cells Differential DNA methylation profiles in gynecological cancers and correlation with clinico-pathological data.BRCA1 interaction with human papillomavirus oncoproteins.Control of death-associated protein kinase (DAPK) activity by phosphorylation and proteasomal degradation Methylation of human papillomavirus 16, 18, 31, and 45 L2 and L1 genes and the cellular DAPK gene: Considerations for use as biomarkers of the progression of cervical neoplasia.Promoter methylation status of the tumor suppressor genes p16 and cadherin 1 in cervical intraepithelial neoplasia An upward trend in DNA p16ink4a methylation pattern and high risk HPV infection according to the severity of the cervical lesion Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer.DNA methylation profiling across the spectrum of HPV-associated anal squamous neoplasia.Tumour suppressor gene methylation and cervical cell folate concentration are determinants of high-risk human papillomavirus persistence: a nested case control study.Integrative genomic approaches in cervical cancer: implications for molecular pathogenesis.Associations between methylation of paternally expressed gene 3 (PEG3), cervical intraepithelial neoplasia and invasive cervical cancer.Promoter hypermethylation-mediated inactivation of multiple Slit-Robo pathway genes in cervical cancer progression Quantitative DNA methylation analysis of candidate genes in cervical cancer.Methylated Host Cell Gene Promoters and Human Papillomavirus Type 16 and 18 Predicting Cervical Lesions and Cancer.Association between human papillomavirus and Epstein - Barr virus DNA and gene promoter methylation of RB1 and CDH1 in the cervical lesions: a transversal study Considerations for targeting malignant stem cells in leukemia.Distinguishing Lung Adenocarcinoma from Lung Squamous Cell Carcinoma by Two Hypomethylated and Three Hypermethylated Genes: A Meta-Analysis.Epigenetic mechanisms in virus-induced tumorigenesis.Current Perspectives on Epigenetic Modifications by Dietary Chemopreventive and Herbal Phytochemicals Cell-based high-throughput screens for the discovery of chemotherapeutic agents.p16(INK4a) and p15(INK4b) gene promoter methylation in cervical cancer patients.Clinical relevance of CDH1 and CDH13 DNA-methylation in serum of cervical cancer patients.Protocadherin PCDH10, involved in tumor progression, is a frequent and early target of promoter hypermethylation in cervical cancer.Risk of second cancers after radiotherapy for cervical cancer.Patterns of genomic loss of heterozygosity predict homologous recombination repair defects in epithelial ovarian cancer.The E-cadherin-beta-catenin complex and its implication in lung cancer progression and prognosis.Critical role for transcription factor C/EBP-beta in regulating the expression of death-associated protein kinase 1.Lacking hypoxia-mediated downregulation of E-cadherin in cancers of the uterine cervix Sequential gene promoter methylation during HPV-induced cervical carcinogenesis Gene discovery in cervical cancer : towards diagnostic and therapeutic biomarkers.RARβ gene methylation is a candidate for primary glioblastoma treatment planning.Quantitative methylation-specific PCR for the detection of aberrant DNA methylation in liquid-based Pap tests

P2860

Q24322023-76228C20-7D78-4D65-B9CB-2545C0060D2D Q24683145-D74D38FA-B7DF-475E-AD43-B4B5294E96FC Q24798522-22E84A29-0779-468E-A1EC-FA160DFE4473 Q24799110-10D53B74-6731-4145-8A6F-FBBE876C40ED Q24804876-9CF922B0-59AD-400E-9BA4-6EC63670124D Q24812104-066EE88F-7E92-4684-9080-64BC8FFB5C94 Q26798393-B61E58EB-31D2-4B2D-953C-9CEC3331EDC1 Q28657964-99655493-8BC9-4CAD-A658-8946F6347136 Q31056438-94D309A7-A96B-471F-8DE1-93EC72EA45CD Q33292263-3D31A702-4426-40C5-BCBB-3F74BB135AE9 Q33655851-589D815D-4D3F-4E55-AB55-5A381EBDD783 Q33733302-B9BD5463-3565-4CC6-9C42-72BA0E4D2266 Q33751094-BC26B738-D72A-44EF-93E3-16C17EE8F333 Q33926462-C4FFC288-99C5-4574-8463-207C38CC418F Q34049709-01F3A390-C68F-4F27-8B33-A7E744BC2882 Q34505483-9577C16E-2ED0-4FA0-A1FD-5698CE535F50 Q34515263-CB0DB78D-1F63-4F3B-970B-8DB1E03080E9 Q34569934-A47E6CC8-23CA-4556-8724-5F71CE6C492A Q34589981-98B4C1B2-12CC-422F-BA18-BE6EE6A114C6 Q34695790-3BA8CD35-9996-433D-8E0A-1C1132F6284C Q35235162-6A3279F5-3BFC-45B9-B885-6EC3CC5B51B0 Q35658044-0BE510F7-1097-4322-B391-B0A2F31FDD08 Q35670508-3D35B67F-1859-436E-B43A-CC3CEAAB932F Q35692619-CEA52CFC-9A21-4DAB-97A8-7426B4675B88 Q35919451-72B90CFC-958B-49EC-96DE-7DD0B18BF5DB Q36001887-8838C51A-D2CF-459D-BE48-D3E5FE591203 Q36003900-24AC63F5-A6BB-45BE-ADA1-0D0DEB6898C0 Q36071888-85D24855-38A1-4462-819D-3D494F77B46F Q36084349-8A70BBCB-0E57-40CB-A9BB-60C88BCE4C7F Q36197208-BDC17A47-71B8-41DE-8A34-10D1D9F50B71 Q36197642-75D35CAA-B6EC-4F9A-80FE-7911BC35C62A Q36352077-3431CFED-72D7-4BCB-B85F-D2806274077E Q36385670-95A75809-E0EA-45BA-A74C-C0E010624A69 Q36429579-9A6941F5-C72D-4E83-B892-8FDE665D50B2 Q36540282-90DD035F-B3FE-40DB-B0E8-03A1C37F9F3F Q36594117-2F8CACBA-2DAA-4EE0-A71C-F2026CBF8792 Q36610652-D8DD1786-4C01-413F-ACF9-B1FA9C927549 Q36982644-DDDA1F4E-4322-46D1-9E86-F3D21DB59D91 Q37025204-5019B4F3-CC7F-47F1-A917-BE125B6EE6A2 Q37111527-6692F7C5-AA4D-4DC1-8760-006B81603119

P2860

Frequent promoter methylation of CDH1, DAPK, RARB, and HIC1 genes in carcinoma of cervix uteri: its relationship to clinical outcome

http://www.wikidata.org/entity/Q24800480

description

2003 nî lūn-bûn

@nan

2003 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Frequent promoter methylation ...... lationship to clinical outcome

@ast

Frequent promoter methylation ...... lationship to clinical outcome

@en

Frequent promoter methylation ...... lationship to clinical outcome

@nl

type

label

Frequent promoter methylation ...... lationship to clinical outcome

@ast

Frequent promoter methylation ...... lationship to clinical outcome

@en

Frequent promoter methylation ...... lationship to clinical outcome

@nl

prefLabel

Frequent promoter methylation ...... lationship to clinical outcome

@ast

Frequent promoter methylation ...... lationship to clinical outcome

@en

Frequent promoter methylation ...... lationship to clinical outcome

@nl

P1433

Q24800480-4A2AE32C-D15B-4D6B-AF37-92FBD2BAB0F5

P1476

Q24800480-6CC7DE0C-B5FE-46A6-9552-7AD49AA0DCB2

P2093

Q24800480-11571641-4D03-4C73-B11C-F319C4D24A86

Q24800480-590D76DA-E3CB-4FB4-B11F-14C2997DD5A2

Q24800480-843929C3-0531-409F-9901-63D1A650112B

Q24800480-9085FEA0-4160-4220-9951-9183C08B9277

Q24800480-A2A49DD4-303C-433C-B52F-1A93132F8127

Q24800480-BF9B4C1A-AD02-4966-BB04-0E6A5B65010B

Q24800480-C0B623A1-5573-4B4B-9162-3D60B6BFB19B

Q24800480-DCC760A0-27E6-49C0-9437-3E7CF5DF1064

P2860

Q24800480-03DF5D75-8FE5-41EB-B257-9D1CDAE09C91

Q24800480-0FB738CC-D61C-4DB6-B7D0-503BEE273269

Q24800480-1ED79AC2-B0B0-4232-99C2-52C0DEC66E05

Q24800480-23590922-6DD9-4D90-B0E9-6FA0C58D6A52

Q24800480-252065DE-EC7F-46BE-9050-9158FD4A0C52

Q24800480-2B31BD15-22E9-46A7-97CD-D64C0FC345EF

Q24800480-312E8FC1-05E7-48B5-84AB-D9BF0A546B85

Q24800480-342F9A9A-393A-4F52-9088-EE2E9CDF39BC

Q24800480-3F35E1E5-C2DE-4E5E-B106-DB4572C401E0

Q24800480-446DBCE0-6817-4D38-B4BA-609C85A8EA20

P2888

Q24800480-439A9E32-EE9F-4EED-BC0C-EDEC4EFAAE14

P304

Q24800480-03ACBA24-3A29-4164-893D-716D5CAAF75E

P31

Q24800480-1E86807E-31D6-405A-A67A-FA0E54991A5A

P3181

Q24800480-1E3C7F83-AF11-49CD-A9A5-F5E75553EE40

P356

Q24800480-A8AE2A06-6970-4BF9-85B4-590A7AC1265C

P407

Q24800480-22DEFA4E-F448-4533-A7C5-10B0920C4836

P433

Q24800480-A4FB2C4A-8A4C-45CC-A21C-25E7122610FA

P478

Q24800480-C397B81A-249A-477D-85C3-E97F78538069

P50

Q24800480-57E4576B-78BC-4C52-80AC-B25ED75B6422

Q24800480-DC127FE9-DD63-487C-9724-18AC03CEAD07

P577

Q24800480-C475A3E0-04E0-4716-8A46-004BF1FBFD28

P5875

Q24800480-0E254AD2-0125-413B-98B0-230C9FE5FC34

P6179

Q24800480-2978E483-AC8F-42C9-87C0-88729EC7627A

P698

Q24800480-96AE86BF-E96D-49BE-B574-A9DDB2FCB146

P932

Q24800480-ADC768B2-36F3-443C-9116-035A4ED220C1

P3181

P356

P1433

Molecular Cancer

P1476

Frequent promoter methylation ...... lationship to clinical outcome

@en

P2093

Achim Schneider

http://www.w3.org/2001/XMLSchema#string

Fang F Zhang

http://www.w3.org/2001/XMLSchema#string

Gopeshwar Narayan

http://www.w3.org/2001/XMLSchema#string

Hernan Vargas

http://www.w3.org/2001/XMLSchema#string

Jeannine Villella

http://www.w3.org/2001/XMLSchema#string

Mahesh Mansukhani

http://www.w3.org/2001/XMLSchema#string

Sanjay Koul

http://www.w3.org/2001/XMLSchema#string

Vundavalli V Murty

http://www.w3.org/2001/XMLSchema#string

P2860

Identification of a novel serine/threonine kinase and a novel 15-kD protein as potential mediators of the gamma interferon-induced cell death

p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

Mapping common deleted regions on 5p15 in cervical carcinoma and their occurrence in precancerous lesions.

Characteristic promoter hypermethylation signatures in male germ cell tumors

Methylation and silencing of the retinoic acid receptor-beta 2 gene in cervical cancer

Inactivation of the DNA-repair gene MGMT and the clinical response of gliomas to alkylating agents.

The fundamental role of epigenetic events in cancer

A gene hypermethylation profile of human cancer

Cancer statistics, 2002

P2888

P304

24

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4014036

http://www.w3.org/2001/XMLSchema#string

P356

10.1186/1476-4598-2-24

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

2

http://www.w3.org/2001/XMLSchema#string

P50

Hugo Arias-Pulido

Mary Beth Terry

P577

2003-05-13T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10737855

http://www.w3.org/2001/XMLSchema#string

P6179

1052143664

http://www.w3.org/2001/XMLSchema#string

P698

12773202

http://www.w3.org/2001/XMLSchema#string

P932

156646

http://www.w3.org/2001/XMLSchema#string